Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Acquisitions (2023)

Catheter Precision (VTAK) has disclosed Acquisitions for 1 consecutive years, with -$72.5 million as the latest value for Q4 2023.

  • On a quarterly basis, Acquisitions changed N/A to -$72.5 million in Q4 2023 year-over-year; TTM through Sep 2024 was -$72.5 million, a 199.98% decrease, with the full-year FY2023 number at $15000.0, changed N/A from a year prior.
  • Acquisitions was -$72.5 million for Q4 2023 at Catheter Precision, down from -$10.4 million in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $82.9 million in Q1 2023 to a low of -$72.5 million in Q4 2023.